Your browser doesn't support javascript.
loading
Coping and Perception of Prognosis in Patients With Indolent Non-Hodgkin's Lymphoma.
Newcomb, Richard A; Johnson, P Connor; Yang, Daniel; Holmbeck, Katherine; Choe, Joanna; Nabily, Anisa; Lark, Porsha; Dhawale, Tejaswini; Amonoo, Hermioni L; El-Jawahri, Areej.
Afiliação
  • Newcomb RA; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Johnson PC; Harvard Medical School, Boston, MA, USA.
  • Yang D; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Holmbeck K; Harvard Medical School, Boston, MA, USA.
  • Choe J; Duke University School of Medicine, Durham, NC, USA.
  • Nabily A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Lark P; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Dhawale T; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Amonoo HL; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • El-Jawahri A; Division of Hematology and Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Oncologist ; 2023 Nov 03.
Article em En | MEDLINE | ID: mdl-37935593
ABSTRACT

BACKGROUND:

Indolent non-Hodgkin's lymphomas (iNHL) are a heterogenous group of mostly incurable diseases with prolonged illness courses and prognostic uncertainty. Yet, studies evaluating coping and perception of prognosis are limited.

METHODS:

We conducted a cross-sectional study of adults newly diagnosed with iNHL in the past 3 months at a single academic center. We assessed quality of life (QOL Functional Assessment of Cancer Therapy-General), psychological symptoms (Hospital Anxiety and Depression Scale), coping (Brief-COPE), and perception of prognosis (Prognosis Awareness Impact Scale).

RESULTS:

We enrolled 70.6% (48/68) of eligible patients. Patients had older age (mean = 66.9,sd = 10.5), were female (60.4%), predominantly identified as White (85.4%), and had at least received a college degree (75%). Chronic lymphocytic leukemia (39.6%) and follicular lymphoma (33.3%) were the most common diagnoses. Overall, 27.1% and 14.6% of patients reported clinically significant anxiety and PTSD symptoms, respectively. Patients highly utilized acceptance (56.2%), seeking emotional support (47.9%), and denial (47.9%) as coping strategies at diagnosis. While 66.7% of patients recalled their oncologist assessment of illness as incurable, only 35.4% reported that the illness is unlikely to be cured. Overall, 45.8% indicated that they were worried about prognosis and 31.2% reported perseverating on their prognosis. Higher emotional coping with prognosis was associated with fewer anxiety (B = -0.6, SE = 0.2, P < .001), depression (B = -0.3, SE = .1, P = .005), and PTSD (B = -1.3, SE = 0.4, P < .001) symptoms and better QOL (B = 1.7, SE = 0.4, P < .001).

DISCUSSION:

Patients with iNHL report substantial psychological distress, a diversity of coping strategies, and complex cognitive understanding of their prognosis. Interventions, which address prognostic uncertainty and promote positive emotional coping with prognosis, may ameliorate psychological distress in this population.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Oncologist Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos